NCT06634056 Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation Status NOT_YET_RECRUITING Phase PHASE2
NCT06633536 Real-life Treatment Outcomes of Ravulizumab in PNH Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06630325 A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT06627647 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC Status RECRUITING Phase PHASE3
NCT06613516 Effect of Capivasertib on ctDNA in ER Positive Breast Cancer Status WITHDRAWN Phase PHASE2
NCT06611423 AZD3427 Effects on Renal Perfusion in Heart Failure Patients With Reduced Ejection Fraction and Renal Impairment Status TERMINATED Phase PHASE1
NCT06611345 A Study of Tumor-Treating Fields in Combination With Durvalumab and Gemcitabine/Cisplatin in Biliary Tract Cancers Status RECRUITING Phase NA
NCT06610526 A Study of Dapagliflozin in Chinese Adult Patients With Chronic Kidney Disease Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06607757 Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer Status RECRUITING Phase PHASE2
NCT06607393 CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS3] Status COMPLETED Phase N/A
NCT06606847 A Study to Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation in Participants With Locally Advanced Unresectable Non-Small Cell Lung Cancer (LADOGA) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06605885 An Observational, Prospective, Multicenter Study to Evaluate the Biologic Use and Outcomes in Chinese Asthma Patients Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06599502 A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation Status TERMINATED Phase PHASE1
NCT06595238 A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity Status COMPLETED Phase PHASE2
NCT06594068 Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users Status RECRUITING Phase PHASE4
NCT06592482 A Phase I Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD0780 Status COMPLETED Phase PHASE1
NCT06590740 Establish FeNO Cut-off Value for Predicting Budesonide-formoterol Response in Chronic Cough Suggestive of CVA Patients. Status COMPLETED Phase PHASE4